These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3953293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R, Meyer J, Schweizer P, Lambertz H, Voelker W, Effert S.
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
    Branzi A, Binetti G, Specchia S, Magelli C, Zannoli R, Magnani B.
    Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF, Ireland MA, Littler WA.
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL, Carlsen JE, Hartling OJ, Trap-Jensen J.
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [Abstract] [Full Text] [Related]

  • 9. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
    Tydén H, Johansson L, Nyström SO.
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W, Schütt M, Hamm CW, Kuck KH, Hanrath P, Bleifeld W.
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F, Estrada-Yamamoto M, Reiz S, Reyes C, Hjalmarson A.
    Acta Med Scand Suppl; 1982 Aug; 659():221-31. PubMed ID: 6127891
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC, Walton JA, Brymer JF, Beauman G, Pitt B.
    J Cardiovasc Pharmacol; 1984 Aug; 6(5):852-8. PubMed ID: 6209491
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
    Wahr DW, Swedberg K, Rabbino M, Hoyle MJ, Curran D, Parmley WW, Chatterjee K.
    Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
    [Abstract] [Full Text] [Related]

  • 17. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE, Bohn I, Hahn B, Kment A, Motz U.
    J Cardiovasc Pharmacol; 1984 Jun; 6(3):491-8. PubMed ID: 6202977
    [Abstract] [Full Text] [Related]

  • 18. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S, Høilund-Carlsen PF, Hesse B, Hartling OJ, Fabricius J, Dige-Petersen H, Giese J.
    Eur J Clin Pharmacol; 1984 Jun; 27(5):539-43. PubMed ID: 6151507
    [Abstract] [Full Text] [Related]

  • 19. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F, Baldi G, Bolognesi R, Ferrari R, Visioli O.
    J Cardiovasc Pharmacol; 1984 Jun; 6(5):822-8. PubMed ID: 6209486
    [Abstract] [Full Text] [Related]

  • 20. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
    Muir AL, Hannan WJ, Dewhurst NG, Slessor IM.
    Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.